Literature DB >> 24395486

Recent considerations in recurrent cellulitis.

Larry M Baddour1.   

Abstract

Cellulitis is a frequently diagnosed syndrome that causes considerable morbidity. For a subset of patients, recurrent bouts of infection impact their quality of life. Most cases are due to b-hemolytic streptococci or Staphylococcus aureus. Inclusion of interdigital space (toe web) or mucosal (anal) swab cultures may increase the ability to define pathogens among patients with lower extremity cellulitis. The pathogenesis of cellulitis is complex, and more work is needed so that novel therapies and vaccines can be developed to improve treatment and prevention of this disorder.

Entities:  

Year:  2007        PMID: 24395486     DOI: 10.1007/s11908-007-1003-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  24 in total

1.  Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity.

Authors:  B K Eriksson
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

3.  Lymphoscintigraphic evaluation in patients after erysipelas.

Authors:  J M de Godoy; M F de Godoy; A Valente; E L Camacho; E V Paiva
Journal:  Lymphology       Date:  2000-12       Impact factor: 1.286

4.  Biopsy specimen findings in patients with previous lower extremity cellulitis after saphenous venectomy for coronary artery bypass graft surgery.

Authors:  L M Baddour; P B Googe; S L Stevens
Journal:  J Am Acad Dermatol       Date:  1997-08       Impact factor: 11.527

5.  Cellulitis complicating lymphoedema.

Authors:  P C Woo; P N Lum; S S Wong; V C Cheng; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-04       Impact factor: 3.267

6.  Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema.

Authors:  A Szuba; J P Cooke; S Yousuf; S G Rockson
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

Review 7.  Lymphedema.

Authors:  S G Rockson
Journal:  Am J Med       Date:  2001-03       Impact factor: 4.965

Review 8.  Breast cellulitis complicating breast conservation therapy.

Authors:  L M Baddour
Journal:  J Intern Med       Date:  1999-01       Impact factor: 8.989

9.  Cellulitis syndromes: an update.

Authors:  L M Baddour
Journal:  Int J Antimicrob Agents       Date:  2000-03       Impact factor: 5.283

10.  Changing bacteriology of periorbital cellulitis.

Authors:  G R Schwartz; S W Wright
Journal:  Ann Emerg Med       Date:  1996-12       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.